Pierre Armand Morgon

Pierre Armand Morgon

Chairman bei EUROCINE VACCINES AB

Vermögen: 25 004 $ am 31.03.2024

61 Jahre
Health Technology
Consumer Services
Finance

Profil

Pierre Armand Morgon is currently the CEO of Mrgn Advisors and Drug Abuse Sciences.
He is also the Chief Executive Officer & Manager of MRGN Advisors SARL.
Additionally, he holds the position of Chairman at Eurocine Vaccines AB, Kupando GmbH, MYCB1 Group BV, MYCB1 BV, Health Technology Holding Srl, and Amoéba SA. He serves as a Non-Executive Director at Univercells SA and Limula Biotech.
Furthermore, he is an Independent Non-Executive Director at Barinthus Biotherapeutics Plc and an Advisor at CUBE Labs Srl.
In the past, Dr. Morgon has worked as the Chief Executive Officer of AJ Biologics Sdn.
Bhd.
and as the Chairman of Virometix AG and Alma Biotherapeutics.
He has also held positions as a Marketing Director at Cegedim SA, an Independent Director at Theradiag SA, and an Independent Non-Executive Director at CanSino Biologics, Inc. He served as a Director at Schering-Plough SAS and as a Non-Executive Director at Vaccitech (UK) Ltd.
Additionally, he was the Chief Operating Officer at Valerio Therapeutics SA and the VP-Franchise & Global Marketing Strategy at Sanofi Pasteur.
Dr. Morgon's education includes an undergraduate degree from INSEAD and the International Institute for Management Development, an MBA from ESSEC Business School, a doctorate from the University of Lyon, and a graduate degree from Jean Moulin University Law School.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
13.03.2024 10 506 ( 0,03% ) 25 004 $ 31.03.2024

Aktive Positionen von Pierre Armand Morgon

UnternehmenPositionBeginn
EUROCINE VACCINES AB Chairman 01.06.2019
AMOÉBA Director/Board Member 17.12.2020
BARINTHUS BIOTHERAPEUTICS PLC Director/Board Member 01.01.2018
Drug Abuse Sciences Chief Executive Officer 01.01.2006
Director/Board Member -
Consultant / Advisor -
Chairman 01.12.2021
MYCB1 BV Chairman 01.07.2020
MRGN Advisors SARL Chief Executive Officer -
░░░░░░░ ░░ ░░░░░░░░ -
░░░░░ ░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░░
Alle aktiven Positionen von Pierre Armand Morgon

Ehemalige bekannte Positionen von Pierre Armand Morgon

UnternehmenPositionEnde
░░░░░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░ ░░░░░░░░░ ░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░ ░░░░░ ░ ░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Pierre Armand Morgon im Detail an

Ausbildung von Pierre Armand Morgon

INSEAD Undergraduate Degree
International Institute for Management Development Undergraduate Degree
ESSEC Business School Masters Business Admin
University of Lyon Doctorate Degree
Jean Moulin University Law School Graduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Pierre Armand Morgon im Detail an

Beziehungen

88

Beziehungen ersten Grades

29

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen6
EUROCINE VACCINES AB

Health Technology

CEGEDIM

Technology Services

VALERIO THERAPEUTICS

Health Technology

AMOÉBA

Consumer Non-Durables

CANSINO BIOLOGICS INC.

Health Technology

BARINTHUS BIOTHERAPEUTICS PLC

Health Technology

Private Unternehmen18

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Commercial Services

Alma Biotherapeutics

Mrgn Advisors

Drug Abuse Sciences

Finance

Health Technology

Commercial Services

Health Technology

MYCB1 Group BV

MRGN Advisors SARL

MYCB1 BV

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Pierre Armand Morgon